Ovarian cancer tends to be resistant to hormone therapy, even when it should theoretically respond. Wistar Institute ...
A new study published in the journal Scientific Reports shows that Claudin-4, a protein that increases in ovarian cancer, may be the culprit behind the cancer’s resistance, helping tumors both survive ...
Memorial Sloan Kettering Cancer Center researchers continued to make strides against cancer in 2025. Learn about some of ...
Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope to ovarian cancer ...
Baystreet.ca News Commentary – The FDA issued multiple breakthrough approvals for oncology drugs in November 2025, marking a transformative month for cancer treatment with ...